A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

NCT00214864 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: docetaxel, capecitabine

Sponsor

Cancer Research Network

Collaborators

[object Object]